Investigation into Health Supplement Linked Deaths
The Osaka-based Kobayashi Pharmaceutical is currently investigating the deaths and hospitalizations associated with a health supplement containing beni kōji.
Company’s Response
Kobayashi Pharmaceutical, a major Japanese drugmaker, is looking into the death of an individual who regularly consumed a health supplement marketed as a cholesterol-lowering pill, which includes beni kōji. The company has issued an apology and recalled the product due to reports of kidney problems among consumers.
Apology and Recall
The company expressed regret for the incident and urged individuals to discontinue using the supplement. They suspect a connection between the product and the reported death due to kidney disease.
Customer Symptoms
Customers who used the supplement reported symptoms such as reduced kidney function, urine discoloration, limb swelling, and fatigue.
Investigation Findings
Kobayashi Pharmaceutical is investigating the presence of potentially harmful substances in the production process, particularly in the molds used during manufacturing.
Beni Kōji Overview
Beni kōji is a type of rice fermented with monascus purpureus, a reddish-purple mold known for its cholesterol-lowering properties. It is also used for color and flavor enhancement in various products.
Recall of Products
The company has requested food and beverage companies to recall products containing beni kōji, as it is a key ingredient supplied by Kobayashi Pharmaceutical to multiple businesses.
